Skip to content
Catalyst

Astragalus membranaceusFinding

Astragalus membranaceus decreases aspartate aminotransferase

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“The Astragalus injection group demonstrated a significantly lower ∆AST [WMD = − 14.23, 95%CI (− 24.17, − 4.30)] compared to the control group, with a statistically significant difference (P < 0.05).”
Quoted verbatim from Effect of Astragalus injection treatment for viral myocarditis: a systematic review and meta-analysis.
This finding among the 50 findings on its endpoint

Astragalus membranaceus

Aspartate aminotransferase

lowers

Effect as reported

−14.23mean difference

CI −24.17 to −4.3

Who
Patients with viral myocarditis; pooled randomised trials in which both arms received conventional treatment and only the experimental arm also received Astragalus injection
Dose studied
Pooled; Astragalus injection about 10 to 60 mL per day, or per kg body weight in some trials, once daily in most

Moderate evidencePMID 39754214 · 2025

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

European journal of medical research
What else it reported1 finding · 0 compounds · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M704C3D83HSJFS559MNVJBGC